EXICURE INC (XCUR:NASDAQ)
$3.16 0.05 (1.6077%)
Analysed EXICURE INC (XCUR:NASDAQ) News Sources
Exicure Highlights Recent Achievements and Near-term Strategic Priorities
06-10-2025
yahoo.com
New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting
03-11-2025
yahoo.com
Exicure, Inc. Reports Third Quarter 2025 Financial Results
07-11-2025
yahoo.com
Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting
08-12-2025
yahoo.com
Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings
21-01-2026
yahoo.com
Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant
05-02-2026
yahoo.com
Exicure, Inc. Reports Full Year 2025 Financial Results
25-03-2026
yahoo.com
Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
02-04-2026
yahoo.com
Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
22-04-2026
yahoo.com
Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q
01-06-2026
yahoo.com
What is the current price of EXICURE INC (XCUR:NASDAQ)?
The current price of EXICURE INC (XCUR:NASDAQ) is $3.16.
EXICURE INC (XCUR:NASDAQ) absolute price change since previous trading day?
The absolute price change of EXICURE INC (XCUR:NASDAQ) since the previous trading day is $0.05.
EXICURE INC (XCUR:NASDAQ) percentage price change since previous trading day?
The percentage price change of EXICURE INC (XCUR:NASDAQ) since the previous trading day is 1.6077%.
What is the most recent average sentiment score for EXICURE INC (XCUR:NASDAQ)?
The most recent average sentiment score for EXICURE INC (XCUR:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for EXICURE INC (XCUR:NASDAQ)?
The most recent sentiment for EXICURE INC (XCUR:NASDAQ) is .
SEC-8K** Filing Available For EXICURE INC (XCUR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.